Get the Stockscreener App
71.80
0.80%
0.57
Pre-market:
71.71
-0.09
-0.13%
Liquidia Corp stock is traded at $71.80, with a volume of 2.10M.
It is up +0.80% in the last 24 hours and up +26.12% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
See More
Previous Close:
$71.23
Open:
$72.615
24h Volume:
2.10M
Relative Volume:
1.43
Market Cap:
$6.39B
Revenue:
$288.07M
Net Income/Loss:
$22.31M
P/E Ratio:
507.06
EPS:
0.1416
Net Cash Flow:
$41.15M
1W Performance:
+12.36%
1M Performance:
+26.12%
6M Performance:
+110.00%
1Y Performance:
+409.22%
1-Day Range:
$68.56
$72.61
1-Week Range:
$61.72
$72.70
52-Week Range:
$11.85
$72.70
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
71.80 | 6.39B | 288.07M | 22.31M | 41.15M | 0.1416 |
TAK
Takeda Pharmaceutical Co Adr
|
15.77 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.07 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.69 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.95 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.57 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
Liquidia (LQDA) HR chief sells 24,880 shares under 10b5-1 plan - Stock Titan
Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth - Stocktwits
Liquidia (LQDA) Stock Valuation After New YUTREPIA Data And PHA 2026 Conference Plans - Yahoo Finance
[Form 4] Liquidia Corp Insider Trading Activity - Stock Titan
LQDA (NASDAQ) Rule 144 notice lists 3 recent dispositions by affiliate - Stock Titan
Hedge Fund and Insider Trading News: Ken Griffin, Eli Casdin, Catherine D. Wood, Ray Dalio, Two Sigma Advisors, Elliott Investment Management, ExodusPoint Capital, Millennium Management, Liquidia Corp (LQDA), Ramaco Resources Inc (METC), and M - Insider Monkey
Liquidia Technologies stock hits all-time high at 67.06 USD - Investing.com
Insider Selling: Stephen M Bloch Unloads $14.27M Of Liquidia Stock - Benzinga
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions - The Manila Times
Caregivers’ mental health in focus as Liquidia takes PH research to Dallas - Stock Titan
LQDA (NASDAQ) Rule 144 filing; Canaan VIII LP sold 94,365 shares on 06/10/2026 - Stock Titan
Liquidia (LQDA) CDO sells 4,134 shares in tax-related trade - Stock Titan
Venture fund tied to Liquidia (LQDA) director sells 220,835 shares - Stock Titan
Liquidia Corp (NASDAQ:LQDA): Affordable Growth Play With Explosive Revenue - ChartMill
CenterBook Partners LP Sells 359,867 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia Corp (LQDA) Stock Up 3.4% and Still Undervalued -- GF S - GuruFocus
Liquidia (LQDA) Joins S&P SmallCap 600 Index - GuruFocus
Liquidia Corp director Stephen Bloch sells over $5.5m in stock By Investing.com - Investing.com South Africa
Liquidia Corp director Stephen Bloch sells over $5.5m in stock - Investing.com Australia
Liquidia director Paul B. Manning sells $12.8 million in shares By Investing.com - Investing.com Nigeria
Liquidia director Paul B. Manning sells $12.8 million in shares - Investing.com
Liquidia (LQDA) director Paul Manning sells 200,000 shares but retains large stake - Stock Titan
Liquidia added to S&P SmallCap 600 ahead of June 22 trading - TradingView
Liquidia (LQDA) set for S&P SmallCap 600 index inclusion on June 22 - Stock Titan
Canaan fund tied to Liquidia (LQDA) director sells 84,800 shares but keeps large stake - Stock Titan
Canaan VIII LP seeks to sell 200,000 LQDA shares via Form 144 (LQDA) - Stock Titan
Liquidia to join S&P SmallCap 600 index on June 22 - Investing.com
Liquidia to join S&P SmallCap 600 index effective June 22 By Investing.com - Investing.com Canada
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index - Yahoo Finance
How YUTREPIA Profitability and Patent Tailwinds At Liquidia (LQDA) Has Changed Its Investment Story - Yahoo Finance
WCG Wealth Advisors LLC Boosts Stock Holdings in Liquidia Corporation $LQDA - MarketBeat
LQDA Maintains Buy Rating by HC Wainwright & Co. -- Price Target Raised to $75.00 - GuruFocus
H.C. Wainwright Maintains Liquidia(LQDA.US) With Buy Rating, Raises Target Price to $75 - Moomoo
What Liquidia (LQDA)'s Profitable Quarters and Patent Tailwinds Mean For Shareholders - simplywall.st
H.C. Wainwright raises Liquidia stock price target to $75 on legal outlook - Investing.com
Liquidia executives take business update to two May investor events - Stock Titan
LQDA News | LIQUIDIA CORP (NASDAQ:LQDA) - ChartMill
Liquidia (LQDA) Sees Remarkable 17.6% Increase in Stock Price - GuruFocus
Liquidia (LQDA) Receives Strong Buy Rating from Raymond James - GuruFocus
Liquidia Corp (LQDA) Shares Surge 12.3% -- What GF Score of 75 T - GuruFocus
LQDA (Nasdaq) Form 144: Director notice to sell 200,000 shares on 06/04/2026 - Stock Titan
Raymond James reiterates Strong Buy on Liquidia stock on Supreme Court case - Investing.com
Rule 144 Notice — LQDA (NASDAQ: LQDA) Resale and Recent Sale Details - Stock Titan
BTIG raises Liquidia stock price target to $50 on strong launch - Investing.com
Liquidia (LQDA) HR chief sells 276 shares to cover RSU tax - Stock Titan
[144] Liquidia Corp SEC Filing - Stock Titan
Liquidia Corp stock (US53634H1077): momentum rally puts valuation metrics in focus after strong year - AD HOC NEWS
Entity linked to Liquidia (LQDA) CEO sells 6,428 shares in plan trade - Stock Titan
Liquidia Corporation (LQDA) Leads Healthcare Stocks with 66.11% Gains - GuruFocus
Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice - Yahoo Finance
Is It Too Late to Buy Liquidia Corp (LQDA) After 3.2% Rally? GF Value Says Undervalued - GuruFocus
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Liquidia Corp Stock (LQDA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bloch Stephen M | Director |
Jun 11 '26 |
Sale |
70.43 |
242,269 |
17,062,444 |
1,176,184 |
| Bloch Stephen M | Director |
Jun 10 '26 |
Sale |
65.58 |
145,954 |
9,572,345 |
1,418,453 |
9.24%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):